Innoviva Strategic Opportunities LLC, Director, 10% Owner at Armata Pharmaceuticals, Inc. (ARMP), bought 1,867,912 shares at $3.25 ($6.1M) on 2021-01-26, disclosed to the SEC on 2021-01-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| ARMP | BUY | 2021-11-01 | $8.0M | — | Filing → |
| ETTX | BUY | 2021-06-11 | $12.5M | — | Filing → |